INDICATION

VPRIV is a hydrolytic lysosomal glucocerebroside-specific enzyme indicated for long-term enzyme replacement therapy (ERT) for pediatric and adult patients with type 1 Gaucher disease.

IMPORTANT SAFETY INFORMATION

Please see full Prescribing Information from a Shire representative at booth 1406-1511, or click here.

Top